Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Finasteride effectively treats male hair loss, increasing length and thickness.

Dutasteride helps slow hair loss and boosts hair growth.

Minoxidil 3% lotion is effective and safe for increasing beard hair count.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

PRP shows promise for treating female hair loss but needs more research.

Platelet Rich Plasma (PRP) treatment significantly improved Female Pattern Hair Loss in a study, but more trials are needed for confirmation.

Stand-alone PRP therapy effectively increases hair density for hair loss treatment.

PRP is effective and safe for increasing hair density in people with hair loss.

Topical prostaglandin analogs may help with hair growth but more research is needed.

Placebo effects vary in hair loss trials, with split-scalp trials showing higher hair density after 6 months compared to whole-head trials.

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

5% minoxidil works better for hair growth and density, with minor irritation.

Minoxidil helps hair growth and reduces shedding in women.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

1% topical cetirizine may help treat hair loss but is less effective than minoxidil.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Saw palmetto can help with prostate issues and may promote hair growth.

1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.

Minoxidil solution can cause skin irritation and allergies in some users.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Inositol was not more effective than a placebo in treating trichotillomania.

Melatonin implants did not effectively prevent hair loss in dogs.

The moisturizer with phytol improved skin texture and reduced fine wrinkles better than the moisturizer without it.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Platelet-rich plasma injections effectively increase hair density in men suffering from common hair loss.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Placebo effects in alopecia treatments are likely due to study design, not real improvement.